Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Commercial
NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November…
Commercial
OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the…
Commercial
BioSpace Movers & Shakers, Oct. 30
Commercial
Q32 Stays Busy with $60 Million Series B and First Dose…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide…
Commercial
Oyster Point Pharma to Report Third Quarter 2020 Financial Results on…
Commercial
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Commercial
Trevena, Inc. Announces DEA Scheduling of OLINVYK (oliceridine) injection – FirstWord…
Home
Commercial
Commercial
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Commercial
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide Corporate Update on Tuesday, November 10, 2020
Biospace News
-
November 10, 2020
Commercial
Oyster Point Pharma to Report Third Quarter 2020 Financial Results on November 5, 2020 Nasdaq:OYST
Commercial
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Thursday, November 5, 2020
Commercial
Trevena, Inc. Announces DEA Scheduling of OLINVYK (oliceridine) injection – FirstWord Pharma
Commercial
New TEPEZZA (teprotumumab-trbw) Data to Be Presented at the American Academy of Ophthalmology 2020 Annual Meeting – FirstWord Pharma
Commercial
FTC nod clears way for merger between Pfizer’s Upjohn unit, Mylan...
Firstwordpharma News
-
October 31, 2020
0
Commercial
High-Dose Quadrivalent Influenza Vaccine Shows Favourable Phase 2 Trial Results in...
Firstwordpharma News
-
October 31, 2020
0
Commercial
Novel Scoring System Differentiates Viral From Bacterial Pneumonia in Hospitalised Children:...
Firstwordpharma News
-
October 31, 2020
0
Commercial
BCG Vaccination at Birth Reduces Incidence of Non-Tuberculosis Infections in Newborns:...
Firstwordpharma News
-
October 31, 2020
0
Commercial
Ocumension Therapeutics Strengthens Pipeline for Posterior Segment Eye Diseases – FirstWord...
Firstwordpharma News
-
October 31, 2020
0
1
2
3
...
600
Page 1 of 600
- Advertisement -
MOST POPULAR
Galapagos creates new warrant plans
April 10, 2019
Polyphor and the University of Zurich receive an award from Innosuisse...
May 29, 2019
Scottish Medicines Consortium abemaciclib (Verzenios)
May 13, 2019
Geron to Announce Fourth Quarter and Full Year 2019 Financial Results...
March 5, 2020
Load more
HOT NEWS
Commercial
BioPharmX Announces $3.9 Million Offering
Others
BioSyent Announces Notice of Deficiency for Cardiovascular Products
Others
Phio Pharmaceuticals to Highlight Self-delivering RNAi Technology at SITC 2019
Others
CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) – Dec....
